Cytokinetics (CYTK) Accounts Payables (2016 - 2025)
Historic Accounts Payables for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to $11.6 million.
- Cytokinetics' Accounts Payables fell 1605.54% to $11.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.6 million, marking a year-over-year decrease of 1605.54%. This contributed to the annual value of $21.5 million for FY2023, which is 1602.44% down from last year.
- As of Q3 2024, Cytokinetics' Accounts Payables stood at $11.6 million, which was down 1605.54% from $9.5 million recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Accounts Payables peaked at $25.6 million during Q4 2022, and registered a low of $2.9 million during Q2 2020.
- In the last 5 years, Cytokinetics' Accounts Payables had a median value of $13.8 million in 2023 and averaged $13.4 million.
- Its Accounts Payables has fluctuated over the past 5 years, first crashed by 4378.13% in 2020, then soared by 41123.29% in 2021.
- Quarter analysis of 5 years shows Cytokinetics' Accounts Payables stood at $8.0 million in 2020, then soared by 161.95% to $21.1 million in 2021, then rose by 21.45% to $25.6 million in 2022, then fell by 16.02% to $21.5 million in 2023, then plummeted by 46.15% to $11.6 million in 2024.
- Its last three reported values are $11.6 million in Q3 2024, $9.5 million for Q2 2024, and $13.0 million during Q1 2024.